A judge approves Bayer's Roundup deal, swapping open-ended claims for 21 years of payments
A St. Louis judge found the settlement fair, reasonable and adequate, the Guardian and BBC reported; about 200 federal cases remain outside it.
Add FinanceInTime as a preferred source on Google
A Missouri state court judge approved Bayer's $7.25 billion settlement of lawsuits alleging that its Roundup weedkiller causes cancer on Friday, November 20, according to the Guardian and the BBC. The deal is meant to resolve nearly all current and future Roundup claims in the US.
Payments run for up to 21 years
Judge Timothy Boyer of a state court in St. Louis found the settlement "fair, reasonable and adequate", the Guardian reported. The BBC reported that Bayer will make annual payments into a fund for up to 21 years, providing as much as $7.25 billion in total.
The money goes to Roundup users who already have non-Hodgkin lymphoma and to those who fall ill in the future, the BBC said. Individual settlements range from $10,000 to $165,000, depending on how often a person used the product, when the cancer was diagnosed and how severe the illness is.
Bayer faced approximately 65,000 claims in US state and federal courts from people who said they developed cancer after using Roundup at home or on the job, according to the Guardian. The settlement was announced in February.
The judge set aside the objections on payout size
Some attorneys objected that the sums were too low. The Guardian reported that the judge overruled objections that payouts to individual cancer victims would be too low because claimants who previously settled were paid more. He also said delaying payouts could force victims, including some with terminal cancer, to wait "an indeterminate number of years".
Bayer denies that Roundup causes cancer, the BBC said. Bayer Chief Executive Bill Anderson said in a statement that "The court’s final approval is a decisive milestone in the company’s strategy to mitigate the risks of both pending and future Roundup litigation," as quoted by the Guardian.
A Supreme Court ruling narrowed what plaintiffs could win in court
The approval follows a US Supreme Court decision in the Durnell case, which overturned a $1.25 million jury award to a Missouri man, John Durnell, who blamed glyphosate in Roundup for his non-Hodgkin lymphoma, the Guardian reported. The court voted 7-2, agreeing with Bayer that a federal pesticide law barred failure-to-warn claims brought under state law.
Christopher Seeger, a lawyer for many of the plaintiffs, said that decision narrowed the ability of Roundup victims to pursue claims in court, the Guardian reported.
About 200 federal cases sit outside the deal
The settlement excludes some lawsuits still pending in federal court. The Guardian reported that Bayer has said about 200 of those cases were still being litigated and that the Supreme Court decision gave it strong defenses.
Bayer settled much of the earlier Roundup litigation for $10.9 billion in 2020, according to the Guardian, and its share price had fallen 46% since it bought Monsanto for $63 billion in 2018.
We would read the 21-year schedule as the real news for Bayer's cash
We think the approval matters less as a headline total than as a change in the kind of risk Bayer carries: open-ended verdicts become annual payments over up to 21 years, a stream a business can plan around. The opportunity is predictability; the threat is that payments run for up to 21 years and that about 200 federal cases are still open.
We would watch how Bayer's annual payments compare with the cash it generates, and whether the remaining federal cases shrink in light of the Supreme Court ruling. We expect the legal overhang to ease if those cases keep losing ground, and our view would change if the objecting lawyers succeed in reopening the approval.
The view in this final section is FinanceInTime's editorial opinion, for information only. It is not investment, tax, legal or other advice, and it does not take your circumstances into account. Forecasts are uncertain and past results do not guarantee future ones.
Sources
- Judge approves $7.25bn Bayer payout to settle claims that Roundup causes cancer — The GuardianSecondary source
- Judge approves $7.25bn settlement for Roundup weedkiller cancer claims — BBC NewsSecondary source
More in Business
View All Business


